fluorescein has been researched along with fluorometholone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avunduk, AM; Avunduk, MC; Kaufman, HE; Varnell, ED | 1 |
| Duszak, RS | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Gong, L; Lin, T | 1 |
2 trial(s) available for fluorescein and fluorometholone
| Article | Year |
|---|---|
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
Topics: Administration, Topical; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Conjunctiva; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Flurbiprofen; Glucocorticoids; Goblet Cells; HLA-DR Antigens; Humans; Male; Middle Aged; Ophthalmic Solutions; Periodic Acid-Schiff Reaction; Prospective Studies; Rose Bengal; Single-Blind Method; Treatment Outcome | 2003 |
Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; China; Cyclosporine; Female; Fluorescein; Fluorometholone; Humans; Hyaluronic Acid; Male; Middle Aged; Ophthalmic Solutions; Sjogren's Syndrome; Viscosupplements | 2015 |
2 other study(ies) available for fluorescein and fluorometholone
| Article | Year |
|---|---|
Diagnosis and management of Thygeson's superficial punctate keratitis.
Topics: Adult; Cornea; Fluorescein; Fluorescent Dyes; Fluorometholone; Follow-Up Studies; Glucocorticoids; Humans; Keratitis; Male; Ophthalmic Solutions; Time Factors | 2007 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |